-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Wangsu Science & Technology Co.,Ltd.'s (SZSE:300017) Popularity With Investors Under Threat As Stock Sinks 25%
Wangsu Science & Technology Co.,Ltd.'s (SZSE:300017) Popularity With Investors Under Threat As Stock Sinks 25%
The Wangsu Science & Technology Co.,Ltd. (SZSE:300017) share price has fared very poorly over the last month, falling by a substantial 25%. The drop over the last 30 days has capped off a tough year for shareholders, with the share price down 19% in that time.
Although its price has dipped substantially, Wangsu Science & TechnologyLtd's price-to-earnings (or "P/E") ratio of 66.1x might still make it look like a strong sell right now compared to the market in China, where around half of the companies have P/E ratios below 27x and even P/E's below 16x are quite common. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly elevated P/E.
Wangsu Science & TechnologyLtd hasn't been tracking well recently as its declining earnings compare poorly to other companies, which have seen some growth on average. It might be that many expect the dour earnings performance to recover substantially, which has kept the P/E from collapsing. If not, then existing shareholders may be extremely nervous about the viability of the share price.
Check out our latest analysis for Wangsu Science & TechnologyLtd
SZSE:300017 Price Based on Past Earnings April 28th 2022 Keen to find out how analysts think Wangsu Science & TechnologyLtd's future stacks up against the industry? In that case, our free report is a great place to start.Is There Enough Growth For Wangsu Science & TechnologyLtd?
There's an inherent assumption that a company should far outperform the market for P/E ratios like Wangsu Science & TechnologyLtd's to be considered reasonable.
Taking a look back first, the company's earnings per share growth last year wasn't something to get excited about as it posted a disappointing decline of 22%. As a result, earnings from three years ago have also fallen 79% overall. Therefore, it's fair to say the earnings growth recently has been undesirable for the company.
Looking ahead now, EPS is anticipated to climb by 23% per annum during the coming three years according to the six analysts following the company. With the market predicted to deliver 26% growth each year, the company is positioned for a weaker earnings result.
In light of this, it's alarming that Wangsu Science & TechnologyLtd's P/E sits above the majority of other companies. Apparently many investors in the company are way more bullish than analysts indicate and aren't willing to let go of their stock at any price. Only the boldest would assume these prices are sustainable as this level of earnings growth is likely to weigh heavily on the share price eventually.
The Final Word
A significant share price dive has done very little to deflate Wangsu Science & TechnologyLtd's very lofty P/E. It's argued the price-to-earnings ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.
We've established that Wangsu Science & TechnologyLtd currently trades on a much higher than expected P/E since its forecast growth is lower than the wider market. When we see a weak earnings outlook with slower than market growth, we suspect the share price is at risk of declining, sending the high P/E lower. Unless these conditions improve markedly, it's very challenging to accept these prices as being reasonable.
There are also other vital risk factors to consider before investing and we've discovered 3 warning signs for Wangsu Science & TechnologyLtd that you should be aware of.
If these risks are making you reconsider your opinion on Wangsu Science & TechnologyLtd, explore our interactive list of high quality stocks to get an idea of what else is out there.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
The Wangsu Science & Technology Co.,Ltd. (SZSE:300017) share price has fared very poorly over the last month, falling by a substantial 25%. The drop over the last 30 days has capped off a tough year for shareholders, with the share price down 19% in that time.
这个望苏科技股份有限公司(SZSE:300017)过去一个月,股价表现非常糟糕,大幅下跌了25%。过去30天的下跌为股东们艰难的一年画上了句号,股价在此期间下跌了19%。
Although its price has dipped substantially, Wangsu Science & TechnologyLtd's price-to-earnings (or "P/E") ratio of 66.1x might still make it look like a strong sell right now compared to the market in China, where around half of the companies have P/E ratios below 27x and even P/E's below 16x are quite common. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly elevated P/E.
尽管其股价大幅下跌,但网苏科技股份有限公司66.1倍的市盈率仍可能使其与中国市场相比看起来是一个强劲的卖盘。在中国,大约一半的公司的市盈率低于27倍,甚至低于16倍的市盈率也很常见。尽管如此,我们还需要更深入地挖掘,以确定市盈率大幅上升是否有合理的基础。
Wangsu Science & TechnologyLtd hasn't been tracking well recently as its declining earnings compare poorly to other companies, which have seen some growth on average. It might be that many expect the dour earnings performance to recover substantially, which has kept the P/E from collapsing. If not, then existing shareholders may be extremely nervous about the viability of the share price.
网苏科技有限公司最近的表现不佳,因为它不断下降的收益比其他公司差,其他公司的平均收益有一些增长。这可能是因为许多人预计低迷的盈利表现将大幅复苏,这使得市盈率没有崩溃。如果不是,那么现有股东可能会对股价的生存能力感到极度紧张。
Check out our latest analysis for Wangsu Science & TechnologyLtd
查看我们对旺苏科技有限公司的最新分析
Is There Enough Growth For Wangsu Science & TechnologyLtd?
旺苏科技有限公司是否有足够的增长空间?
There's an inherent assumption that a company should far outperform the market for P/E ratios like Wangsu Science & TechnologyLtd's to be considered reasonable.
有一种固有的假设,即一家公司的市盈率应该远远超过市场,比如旺苏科技有限公司的市盈率才被认为是合理的。
Taking a look back first, the company's earnings per share growth last year wasn't something to get excited about as it posted a disappointing decline of 22%. As a result, earnings from three years ago have also fallen 79% overall. Therefore, it's fair to say the earnings growth recently has been undesirable for the company.
先回过头来看,该公司去年的每股收益增长并不值得兴奋,因为它公布了令人失望的22%的降幅。因此,三年前的整体收益也下降了79%。因此,公平地说,最近的收益增长对公司来说是不可取的。
Looking ahead now, EPS is anticipated to climb by 23% per annum during the coming three years according to the six analysts following the company. With the market predicted to deliver 26% growth each year, the company is positioned for a weaker earnings result.
根据跟踪该公司的六位分析师的说法,展望未来三年,每股收益预计将以每年23%的速度攀升。由于市场预计每年将实现26%的增长,该公司的盈利结果将变得更加疲软。
In light of this, it's alarming that Wangsu Science & TechnologyLtd's P/E sits above the majority of other companies. Apparently many investors in the company are way more bullish than analysts indicate and aren't willing to let go of their stock at any price. Only the boldest would assume these prices are sustainable as this level of earnings growth is likely to weigh heavily on the share price eventually.
有鉴于此,旺苏科技股份有限公司的市盈率高于其他大多数公司,这令人担忧。显然,该公司的许多投资者比分析师所说的要乐观得多,他们不愿以任何价格抛售自己的股票。只有最大胆的人才会认为这些价格是可持续的,因为这种盈利增长水平最终可能会对股价造成沉重压力。
The Final Word
最后的结论
A significant share price dive has done very little to deflate Wangsu Science & TechnologyLtd's very lofty P/E. It's argued the price-to-earnings ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.
股价的大幅下跌对旺苏科技有限公司非常高的市盈率几乎没有起到什么作用。有人认为,在某些行业,市盈率是衡量价值的次要指标,但它可以成为一个强大的商业信心指标。
We've established that Wangsu Science & TechnologyLtd currently trades on a much higher than expected P/E since its forecast growth is lower than the wider market. When we see a weak earnings outlook with slower than market growth, we suspect the share price is at risk of declining, sending the high P/E lower. Unless these conditions improve markedly, it's very challenging to accept these prices as being reasonable.
我们已经确定,旺苏科技有限公司目前的市盈率远高于预期,因为其预期增长低于大盘。当我们看到疲弱的盈利前景和低于市场的增长时,我们怀疑股价有下跌的风险,导致高市盈率下降。除非这些条件明显改善,否则要接受这些价格是合理的是非常具有挑战性的。
There are also other vital risk factors to consider before investing and we've discovered 3 warning signs for Wangsu Science & TechnologyLtd that you should be aware of.
在投资之前,还有其他重要的风险因素需要考虑,我们发现了旺苏科技有限公司的三个警示信号,你应该知道。
If these risks are making you reconsider your opinion on Wangsu Science & TechnologyLtd, explore our interactive list of high quality stocks to get an idea of what else is out there.
如果这些风险让你重新考虑你对旺苏科技有限公司的看法,探索我们的高质量股票互动列表,以了解还有什么。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有什么反馈吗?担心内容吗?保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
这篇由《华尔街日报》撰写的文章本质上是笼统的。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。简单地说,华尔街在提到的任何股票中都没有头寸。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧